Table 5: Decision for a diagnostic clinical performance trial in the new region (specificity).
Δ |
ρ |
Decision New Region |
Proportion of Subjects for bridging study |
Sample size for bridging study |
|
0.031 |
0.92 |
0.55 |
No Clinical Trial |
. |
. |
0.032 |
0.91 |
0.54 |
No Clinical Trial |
. |
. |
0.033 |
0.89 |
0.52 |
Bridging Study |
0.073 |
122 |
0.034 |
0.88 |
0.51 |
Bridging Study |
0.069 |
|
0.035 |
0.86 |
0.49 |
New Clinical Trial |
. |
. |
0.036 |
0.84 |
0.48 |
New Clinical Trial |
. |
. |